Sequential phase II studies of flavopiridol by 72-hour continuous infusion and 1-hour intravenous bolus for the treatment of relapsed B-cell chronic lymphocytic leukemia: Results from CALGB study 19805.

被引：4

作者：

Byrd, JC

Peterson, BL

Gabrilove, JL

Odenike, OM

Grever, MR

Rai, KR

Vardiman, JW

Larson, RA

机构：

[1] Ohio State Univ, Coll Med, Columbus, OH 43210 USA

[2] Duke Univ, CALGB Stat Ctr, Durham, NC 27706 USA

[3] Mt Sinai Med Ctr, Div Med Oncol, New York, NY USA

[4] Univ Chicago, Chicago, IL 60637 USA

[5] Long Isl Jewish Med Ctr, Div Hematol Oncol, New Hyde Pk, NY 11042 USA

[6] Canc & Leukemia Grp B, Chicago, IL USA

来源：

关键词：

D O I：

10.1182/blood.V104.11.3485.3485

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3485

引用

页码：950A / 950A

页数：1